Department of Clinical Physiology, Nuclear Medicine & PET

Medicine & Life Sciences

1. 1,4,7-triazacyclononane-N,N',N''-triacetic acid 7%
2. 1-(1,3-carboxypropyl)-4,7-carboxymethyl-1,4,7-triazacyclononane 12%
3. 64Cu-DOTATATE 19%
4. Alzheimer Disease 7%
5. Antipsychotic Agents 13%
6. Atherosclerosis 7%
7. Biomarkers 15%
8. Biopsy 7%
9. Blood Pressure 15%
10. Blood-Brain Barrier 7%
11. Bone and Bones 10%
12. Brain 34%
13. Brain Natriuretic Peptide 7%
14. Brain Neoplasms 9%
15. Calcitonin Gene-Related Peptide 7%
16. Cerebrovascular Circulation 19%
17. Cimbi-36 10%
18. Cluster Headache 8%
19. Coronary Artery Disease 7%
20. Cross-Over Studies 8%
21. Deep Learning 7%
22. Denmark 11%
23. Exercise 12%
24. Fluorodeoxyglucose F18 42%
25. Glioblastoma 12%
26. Glioma 8%
27. Glomerular Filtration Rate 8%
28. Glucagon-Like Peptide 1 8%
29. Glucagon-Like Peptide-1 Receptor 7%
30. Glucose 17%
31. Guidelines 9%
32. Head and Neck Neoplasms 8%
33. Headache 7%
34. Healthy Volunteers 20%
35. Heart Failure 8%
36. Heterografts 13%
37. HIV 7%
38. Hodgkin Disease 9%
39. Hypertension 8%
40. Hypoxia 7%
41. Inflammation 8%
42. Injections 7%
43. Kidney 10%
44. Ligands 8%
45. Liposomes 7%
46. Liraglutide 7%
47. Lung 13%
48. Lung Neoplasms 10%
49. Magnetic Resonance Imaging 35%
50. Magnetic Resonance Spectroscopy 10%
51. Migraine Disorders 14%
52. Molecular Imaging 14%
53. Mortality 8%
54. Multiple Sclerosis 8%
55. Muscles 10%
56. Myocardial Infarction 8%
57. Myocardial Perfusion Imaging 11%
58. Neoplasm Metastasis 11%
59. Neoplasms 35%
60. Neuroendocrine Tumors 14%
61. Neuroimaging 12%
62. Nuclear Medicine 13%
63. Pediatrics 8%
64. Peptides 7%
65. Perfusion 29%
66. Photons 7%
67. Placebos 12%
68. Population 8%
69. Positron Emission Tomography Computed Tomography 29%
70. Positron-Emission Tomography 100%
71. Prospective Studies 7%
72. Prostatic Neoplasms 7%
73. Psychotic Disorders 9%
74. Radioisotopes 11%
75. Radionuclide Imaging 14%
76. Radiotherapy 20%
77. Randomized Controlled Trials 10%
78. Receptor, Serotonin, 5-HT2A 19%
79. Receptors, Serotonin, 5-HT4 8%
80. Recurrence 8%
81. Rubidium-82 17%
82. SB 207145 8%
83. Schizophrenia 13%
84. Serotonin 12%
85. Serotonin Plasma Membrane Transport Proteins 8%
86. Single Photon Emission Computed Tomography Computed Tomography 7%
87. Single-Photon Emission-Computed Tomography 19%
88. Skeletal Muscle 8%
89. Somatostatin Receptors 8%
90. Squamous Cell Carcinoma of Head and Neck 8%
91. Stroke Volume 8%
92. Survival 10%
93. Swine 9%
94. Therapeutics 22%
95. Tomography 12%
96. Tumor Burden 8%
97. Type 1 Diabetes Mellitus 7%
98. Type 2 Diabetes Mellitus 12%
99. Urokinase Plasminogen Activator Receptors 22%
100. White Matter 10%